Enniatin Exerts p53-Dependent Cytostatic and p53-Independent Cytotoxic Activities against Human Cancer Cells

Klyszejko A., 2005, Pol. J. Microbiol., 54, 25

Bennett J. W., 2003, Clin. Microbiol. Rev., 16, 10.1128/CMR.16.3.497-516.2003

Jestoi M., 2004, Presence and concentrations of the Fusarium-related mycotoxins beauvericin, enniatins and moniliformin in finnish grain samples. Food Addit. Contam. 21, 794−802

Logrieco A., 2002, Appl. Environ. Microbiol., 68, 85, 10.1128/AEM.68.1.82-85.2002

Thrane U., 2004, Int. J. Food Microbiol., 95, 10.1016/j.ijfoodmicro.2003.12.005

Tomoda H., 1992, J. Antibiot. (Tokyo), 45

Mereish K. A., 1990, Interaction of cyclic peptides and depsipeptides with calmodulin. Pept. Res. 3, 233−237

Kamyar M., 2004, Investigation of the electrophysiological properties of enniatins. Arch. Biochem. Biophys. 429, 215−223

Jow G. M., 2004, Cancer Lett., 216

Lin H. I., 2005, Cancer Lett., 230

Ivanova L., 2006, A1, B, B1, B2 and B3 from Fusarium avenaceum. Toxicon 47, 868−876.

Berger W., 2001, Int. J. Cancer, 94, 10.1002/ijc.1486

Berger W., 1997, Int. J. Cancer, 71

Kubista B., 2006, J. Orthop. Res., 24, 10.1002/jor.20129

Berger W., 1997, Effects of multidrug resistance-related ATP-binding-cassette transporter proteins on the cytoskeletal activity of cytochalasins. Exp. Cell Res. 237, 307−317

Shen D. W., 1986, J. Biol. Chem., 261

McGrath, T., and Center, M. S. (1988) Mechanisms of multidrug resistance in HL60 cells:  Evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug.Cancer Res.48, 3959−3963.

Doyle L. A., 1998, Proc. Natl. Acad. Sci. U.S.A. 95

Bunz, F., Fauth, C., Speicher, M. R., Dutriaux, A., Sedivy, J. M., Kinzler, K. W., Vogelstein, B., and Lengauer, C. (2002) Targeted inactivation of p53 in human cells does not result in aneuploidy.Cancer Res.62, 1129−1133.

Waldman, T., Kinzler, K. W., and Vogelstein, B. (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells.Cancer Res.55, 5187−5190.

Zhang L., 2000, Role of BAX in the apoptotic response to anticancer agents. Science 290, 989−992

Berger W., 1994, Int. J. Cancer, 59, 10.1002/ijc.2910590522

Berger W., 2000, Int. J. Cancer, 88, 10.1002/1097-0215(20001015)88:2<293::AID-IJC23>3.0.CO;2-S

Loo D. T., 1998, Measurement of cell death. Methods Cell Biol. 57, 251−264

Broker L. E., 2005, Cell death independent of caspases:  A review. Clin. Cancer Res. 11, 3155−3162

Polla B. S., 1996, Proc. Natl. Acad. Sci. U.S.A. 93

Cory S., 2002, Nat. Rev. Cancer, 2, 10.1038/nrc883

Gelderblom W. C., 2001, Fumonisin-induced hepatocarcinogenesis:  mechanisms related to cancer initiation and promotion. Environ. Health Perspect. 109 (Suppl. 2), 291−300

Calo L., 2004, Pharmacol. Res., 49, 77

Hiraga K., 2005, Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun. 328, 1119−1125

Rogers B., 2001, J. Mol. Microbiol. Biotechnol., 3

Gottesman M. M., 2002, Nat. Rev. Cancer, 2, 58, 10.1038/nrc706

Spiegl-Kreinecker S., 2002, J. Neurooncol., 57, 36, 10.1023/A:1015735815111

Fadeel B., 2005, J. Intern. Med., 258, 10.1111/j.1365-2796.2005.01570.x

Bouvard, V., Zaitchouk, T., Vacher, M., Duthu, A., Canivet, M., Choisy-Rossi, C., Nieruchalski, M., and May, E. (2000) Tissue and cell-specific expression of the p53-target genes:  Bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.Oncogene19, 649−660.

Yu, J., and Zhang, L. (2005) The transcriptional targets of p53 in apoptosis control.Biochem. Biophys. Res. Commun.331, 851−858.

Zhang Y., 1999, J. Biol. Chem., 274

Abbreviations BEA, beauvericin